Humanin Reduces Amyloid Burden
Author Information
Author(s): Niikura Takako, Sidahmed Elkhansa, Hirata-Fukae Chiho, Aisen Paul S., Matsuoka Yasuji
Primary Institution: Georgetown University
Hypothesis
Does the S14G-HN derivative of Humanin reduce amyloid beta accumulation and improve memory in triple transgenic mice?
Conclusion
S14G-HN treatment reduced amyloid beta levels and improved cognitive function in triple transgenic mice.
Supporting Evidence
- S14G-HN treatment led to lower amyloid beta levels in the brains of treated mice compared to controls.
- Behavioral tests indicated improved cognitive function in S14G-HN treated male mice.
- Neprilysin levels were increased in the hippocampal region of S14G-HN treated mice.
Takeaway
A special protein called Humanin can help mice with Alzheimer's by lowering a harmful substance in their brains and helping them remember better.
Methodology
Triple transgenic mice were treated intranasally with S14G-HN for three months, followed by behavioral tests and analysis of amyloid beta levels.
Potential Biases
Potential bias due to the small sample size and gender differences in response to treatment.
Limitations
The study did not assess the long-term effects of S14G-HN treatment beyond the three-month period.
Participant Demographics
Male and female triple transgenic mice aged 13 months.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website